ANI Pharmaceuticals to Present at Guggenheim's Inaugural Healthcare Innovation Conference and Jefferies London Healthcare Conference in November
ANI Pharmaceuticals (Nasdaq: ANIP) has announced its participation in two major healthcare conferences this November. Nikhil Lalwani, President and CEO, and Stephen Carey, CFO, will present at the Guggenheim Inaugural Healthcare Innovation Conference on November 13, 2024, at 10:00am ET, and the Jefferies London Healthcare Conference on November 20, 2024, at 2:30pm GMT/9:30am ET.
Live and archived webcasts will be available on ANI's website under the Investors section, with replays accessible for 90 days.
ANI Pharmaceuticals (Nasdaq: ANIP) ha annunciato la sua partecipazione a due importanti conferenze sanitarie questo novembre. Nikhil Lalwani, Presidente e CEO, e Stephen Carey, CFO, presenteranno alla Guggenheim Inaugural Healthcare Innovation Conference il 13 novembre 2024 alle 10:00 ET, e alla Jefferies London Healthcare Conference il 20 novembre 2024 alle 14:30 GMT/9:30 ET.
Webcast dal vivo e registrati saranno disponibili sul sito web di ANI nella sezione Investitori, con replay accessibili per 90 giorni.
ANI Pharmaceuticals (Nasdaq: ANIP) ha anunciado su participación en dos importantes conferencias de salud este noviembre. Nikhil Lalwani, Presidente y CEO, y Stephen Carey, CFO, presentarán en la Guggenheim Inaugural Healthcare Innovation Conference el 13 de noviembre de 2024 a las 10:00 ET, y en la Jefferies London Healthcare Conference el 20 de noviembre de 2024 a las 14:30 GMT/9:30 ET.
Las retransmisiones en vivo y archivadas estarán disponibles en el sitio web de ANI en la sección de Inversores, con repeticiones accesibles durante 90 días.
ANI Pharmaceuticals (Nasdaq: ANIP)는 오는 11월 두 개의 주요 의료 회의에 참여할 것이라고 발표했습니다. Nikhil Lalwani 사장 겸 CEO와 Stephen Carey CFO는 2024년 11월 13일 오전 10시(동부 표준시)에 구겐하임 제1회 의료 혁신 회의에서 발표하고, 2024년 11월 20일 오후 2시 30분(GMT)/오전 9시 30분(동부 표준시)에 제퍼리스 런던 의료 회의에서 발표할 예정입니다.
실시간 및 아카이브된 웹캐스트는 ANI 웹사이트의 투자자 섹션에서 이용 가능하며, 다시 보기는 90일 동안 가능합니다.
ANI Pharmaceuticals (Nasdaq: ANIP) a annoncé sa participation à deux grandes conférences sur la santé ce mois de novembre. Nikhil Lalwani, Président et CEO, et Stephen Carey, CFO, présenteront à la Guggenheim Inaugural Healthcare Innovation Conference le 13 novembre 2024 à 10h00 ET, et à la Jefferies London Healthcare Conference le 20 novembre 2024 à 14h30 GMT/9h30 ET.
Des webcasts en direct et archivés seront disponibles sur le site web d'ANI dans la section Investisseurs, avec des rediffusions accessibles pendant 90 jours.
ANI Pharmaceuticals (Nasdaq: ANIP) hat seine Teilnahme an zwei wichtigen Gesundheitskonferenzen im November bekannt gegeben. Nikhil Lalwani, Präsident und CEO, und Stephen Carey, CFO, werden am 13. November 2024 um 10:00 Uhr ET auf der Guggenheim Inaugural Healthcare Innovation Conference und am 20. November 2024 um 14:30 Uhr GMT/9:30 Uhr ET auf der Jefferies London Healthcare Conference präsentieren.
Live- und aufgezeichnete Webcasts werden im Investorenbereich der ANI-Website verfügbar sein, mit Wiederholungen, die 90 Tage lang zugänglich sind.
- None.
- None.
PRINCETON, N.J., Nov. 04, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, President and Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will present at at two upcoming investor conferences as follows:
• The Guggenheim Inaugural Healthcare Innovation Conference
Wednesday, November 13, 2024, at 10:00am ET
• The Jefferies London Healthcare Conference
Wednesday, November 20, 2024, at 2:30pm GMT/9:30am ET
The live and archived webcasts will be accessible from the Company’s website at www.anipharmaceuticals.com, under the Investors section under Events and Presentations. The replay of the webcast will be accessible for 90 days.
About ANI Pharmaceuticals, Inc.
ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company committed to its mission of “Serving Patients, Improving Lives" by developing, manufacturing, and commercializing innovative and high-quality therapeutics. The Company is focused on delivering sustainable growth through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; its Generics business, which leverages R&D expertise, operational excellence, and U.S.-based manufacturing; and its Established Brands business. For more information, visit www.anipharmaceuticals.com.
Investor Relations:
Lisa M. Wilson, In-Site Communications, Inc.
T: 212-452-2793
E: lwilson@insitecony.com
Source: ANI Pharmaceuticals, Inc.
FAQ
When is ANI Pharmaceuticals (ANIP) presenting at the Guggenheim Healthcare Conference in 2024?
What time is ANI Pharmaceuticals (ANIP) presenting at the Jefferies London Healthcare Conference 2024?
How long will ANI Pharmaceuticals' (ANIP) conference webcasts be available for viewing?